205 related articles for article (PubMed ID: 25186596)
1. Myxoid variant of peritoneal epithelioid malignant mesothelioma. A case report.
Goldová B; Dundr P; Zikán M; Tomancová V
Cesk Patol; 2014 Jul; 50(3):149-51. PubMed ID: 25186596
[TBL] [Abstract][Full Text] [Related]
2. Epithelioid angiosarcoma at chest wall which needs to be carefully distinguished from malignant mesothelioma: report of a rare case.
Fan C; Liu Y; Lin X; Han Y; He A; Wang E
Int J Clin Exp Pathol; 2014; 7(12):9056-60. PubMed ID: 25674287
[TBL] [Abstract][Full Text] [Related]
3. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy.
Lee M; Alexander HR; Burke A
Pathology; 2013 Aug; 45(5):464-73. PubMed ID: 23846294
[TBL] [Abstract][Full Text] [Related]
4. Malignant Peritoneal Mesothelioma in an Adolescent Male With BAP1 Deletion.
Taylor S; Carpentieri D; Williams J; Acosta J; Southard R
J Pediatr Hematol Oncol; 2015 Jul; 37(5):e323-7. PubMed ID: 25222065
[TBL] [Abstract][Full Text] [Related]
5. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
Comin CE; Saieva C; Messerini L
Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Kawai T; Tominaga S; Hiroi S; Ogata S; Nakanishi K; Kawahara K; Sonobe H; Hiroshima K
J Clin Pathol; 2016 Aug; 69(8):706-12. PubMed ID: 26729015
[TBL] [Abstract][Full Text] [Related]
7. Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females.
Shanks JH; Harris M; Banerjee SS; Eyden BP; Joglekar VM; Nicol A; Hasleton PS; Nicholson AG
Am J Surg Pathol; 2000 Feb; 24(2):285-94. PubMed ID: 10680897
[TBL] [Abstract][Full Text] [Related]
8. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
9. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
10. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 2003 Aug; 27(8):1031-51. PubMed ID: 12883236
[TBL] [Abstract][Full Text] [Related]
11. Extensive myxoid change in well-differentiated papillary mesothelioma of the pelvic peritoneum.
Diaz LK; Okonkwo A; Solans EP; Bedrossian C; Rao MS
Ann Diagn Pathol; 2002 Jun; 6(3):164-7. PubMed ID: 12089727
[TBL] [Abstract][Full Text] [Related]
12. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
[TBL] [Abstract][Full Text] [Related]
13. Diffuse intrapulmonary malignant mesothelioma presenting with miliary pulmonary nodules: A case report.
Hida T; Hamasaki M; Matsumoto S; Abe S; Takakura K; Hiroshima K; Nabeshima K
Pathol Int; 2015 Jun; 65(6):318-23. PubMed ID: 25759091
[TBL] [Abstract][Full Text] [Related]
14. Two cases of malignant peritoneal mesothelioma without asbestos exposure: cytologic and immunohistochemical features.
Kinoshita Y; Takasu K; Yuri T; Yoshizawa K; Uehara N; Kimura A; Miki H; Tsubura A; Shikata N
Ann Diagn Pathol; 2013 Feb; 17(1):99-103. PubMed ID: 22784439
[TBL] [Abstract][Full Text] [Related]
15. Diffuse malignant biphasic peritoneal mesothelioma with cystic areas.
Cabibi D; Tutino R; Salamone G; Cocorullo G; Agrusa A; Gulotta G
Ann Ital Chir; 2016 Jun; 87():. PubMed ID: 27320084
[TBL] [Abstract][Full Text] [Related]
16. Primary malignant pericardial sarcomatoid mesothelioma: An autopsy report.
Muta H; Sugita Y; Ohshima K; Otsubo H
Pathol Int; 2017 Jun; 67(6):311-315. PubMed ID: 28463437
[TBL] [Abstract][Full Text] [Related]
17. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Am J Surg Pathol; 2001 May; 25(5):610-7. PubMed ID: 11342772
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Cytokeratin 20 Reactivity in Epithelioid Malignant Mesothelioma: A Case Report.
Manur R; Lamzabi I
Appl Immunohistochem Mol Morphol; 2019; 27(10):e93-e96. PubMed ID: 28248731
[TBL] [Abstract][Full Text] [Related]
19. Localized multiple malignant epithelioid peritoneal mesotheliomas arising from the hepatoduodenal ligament and diaphragm: a case report.
Miyata T; Fujiwara Y; Nishijima K; Futagami F; Nakamura T; Takamura H
J Med Case Rep; 2019 Mar; 13(1):66. PubMed ID: 30879467
[TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic Correlation of 13 Cases.
Pavlisko EN; Roggli VL
Am J Surg Pathol; 2015 Nov; 39(11):1568-75. PubMed ID: 26371785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
